EDWARDS LIFESCIENCES CORPORATION | 44,66 Euro | -0,568 -1,26 % | |
| WKN: 936853 ISIN: US28176E1082 Ticker-Symbol: EWL | Frankfurt | 12.12.13 | 08:20 Uhr |
Branche PharmaAktienmarkt S&P 500 |
|
Aktuelle News zu EDWARDS LIFESCIENCES
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
| Leser | Medien | |
|---|---|---|---|---|
| Mi | Shares of Edwards Lifesciences Has Fallen Below Previous 52-Week Low | - | SmarTrend | |
--> Artikel lesen | ||||
| Di | Edwards Lifesciences Corp. Price Target Cut to $64.00 | 2 | i3investor.com | |
--> Artikel lesen | ||||
| Di | Edwards Lifesciences Corp. Price Target Cut to $74.00 by Analysts at Canaccord Genuity | 3 | i3investor.com | |
--> Artikel lesen | ||||
| Di | Edwards Lifesciences Corp. - Analyst/Investor Day | 3 | Seeking Alpha | |
--> Artikel lesen | ||||
| Mo | Look for Shares of Edwards Lifesciences to Potentially Rebound after Yesterday's 5.37% Sell Off | 4 | SmarTrend | |
--> Artikel lesen | ||||
| Mo | Edwards Lifesciences Stock Holds Intra-day Lows Following Guidance Update, Investor Conference | 4 | StreetInsider.com | |
--> Artikel lesen | ||||
| Mo | Edwards Lifesciences Falling Today on Above-Average Volume | 5 | SmarTrend | |
--> Artikel lesen | ||||
| Mo | Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference / 2014 Growth Impacted by Early TAVR Competitive Launches; Strong Pipeline Positions Company for Sustainable Longer-Term Growth; Transcatheter Mitral First-in-Human Procedures to | 12 | Marketwired | |
| NEW YORK, NY -- (Marketwired) -- 12/09/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, will discuss the company's strategy... --> Artikel lesen | ||||
| Fr | The Edwards Lifesciences Fund to Grant ~$5.6 Million to 450+ Non-Profit Organizations in 2013 | 3 | Marketwired | |
| IRVINE, CA -- (Marketwired) -- 12/06/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that The Edwards... --> Artikel lesen | ||||
| Fr | Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's | 3 | PR Newswire | |
| NEW YORK, December 6, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Valeant Pharmaceuticals Intl Inc. (NYSE: VRX), Edwards Lifesciences Corp (NYSE: EW)... --> Artikel lesen | ||||
| 05.12. | CFO Moves: World Wrestling Entertainment, Edwards Lifesciences, Midway Gold | - | WSJ.com | |
--> Artikel lesen | ||||
| 05.12. | Edwards Lifesciences Bullish Moving Average Crossover Alert | - | SmarTrend | |
--> Artikel lesen | ||||
| 05.12. | Edwards Lifesciences Appoints Scott Ullem As CFO | 4 | AFX News | |
| WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) announced that it has appointed Scott Ullem as its corporate vice president, chief financial officer. Ullem will succeed Thomas Abate... --> Artikel lesen | ||||
| 05.12. | Edwards Lifesciences Announces Appointment of CFO | 3 | Marketwired | |
| IRVINE, CA -- (Marketwired) -- 12/05/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has chosen Scott... --> Artikel lesen | ||||
| 28.11. | New Products, Positive Clinical Trial Results, FDA Submissions and Stock Price Updates - Research Report on Pfizer, Cubist, Zoetis, Edwards Lifesciences, and C.R. Bard | 18 | PR Newswire | |
| NEW YORK, November 28, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Pfizer Inc. (NYSE: PFE), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Zoetis Inc. (NYSE:... --> Artikel lesen | ||||
| 22.11. | Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. | 20 | PR Newswire | |
| LONDON, November 22, 2013 /PRNewswire/ --
The U.S. equity market advanced on Thursday, November 21, 2013. The S&P 500 ended the day at 1,795.85, up 0.81%; the Dow Jones Industrial Average closed... --> Artikel lesen | ||||
| 21.11. | SmarTrend Watching for Potential Rebound in Shares of Edwards Lifesciences After 1.38% Loss | 2 | SmarTrend | |
--> Artikel lesen | ||||
| 15.11. | Edwards Lifesciences expands Singapore facility | 5 | The Edge Singapore | |
--> Artikel lesen | ||||
| 15.11. | SINGAPORE PRESS-Edwards Lifesciences expands Singapore facility | 2 | Reuters.com | |
--> Artikel lesen | ||||
| 12.11. | Edwards Lifesciences Corp. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Edwards Lifesciences Corp. and Its Board of Directors and a Lead Plaintiff Deadline of November 18, 2013 - EW | 9 | PR Newswire | |
| NEW YORK, Nov. 12, 2013 /PRNewswire/ --Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on... --> Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
114 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | |
|---|---|---|---|---|
| NOVARTIS | 56,01 | -0,97 % | Novartis: Analysten erwarten Gegenwind | |
| Die Analysten von Vontobel bestätigen das Rating "reduzieren" für die Aktien von Novartis. Das Kursziel sehen sie unverändert bei 62,00 CHF. Sie rechnen mit klarem Gegenwind beim Geschäftsmodell d Den... --> Artikel lesen | ||||
| PFIZER | 22,274 | +0,20 % | Lpath Withdraws From Pfizer' Process To Assign ISONEP Rights | |
| NEW YORK CITY (dpa-AFX) - Lpath Inc. (LPTN) said that it is no longer actively participating in Pfizer's (PFE) process to assign the exclusive option it has for a worldwide license to develop... --> Artikel lesen | ||||
| GILEAD SCIENCES | 51,36 | -0,67 % | Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew | |
| NEW YORK, December 11, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Gilead Sciences, Inc. (NASDAQ: GILD), Life Technologies Corp. (NASDAQ: LIFE), Jazz... --> Artikel lesen | ||||
| GLAXOSMITHKLINE | 18,505 | -1,39 % | Deutsche Bank belässt GlaxoSmithKline auf 'Buy' - Ziel 1800 Pence | |
| Die Deutsche Bank hat die
Einstufung für GlaxoSmithKline (GSK) nach einer Veranstaltung der
amerikanischen Gesellschaft für Hämatologie (ASH) auf "Buy" mit
einem Kursziel von 1800 Pence belassen.... --> Artikel lesen | ||||
| PERRIGO | 109,31 | -2,61 % | Stock Movements, Offered Senior Notes, and Company Announcements - Research Report on Perrigo, Thermo Fisher Scientific, Endo, Waters, and Keryx | |
| NEW YORK, December 12, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting Perrigo... --> Artikel lesen | ||||
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von